NCT03581188View on ClinicalTrials.gov

Patient-led Surveillance Compared to Clinician-led Surveillance in People Treated for Localised Melanoma.

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

February 17, 2020

Study Completion Date

February 17, 2020

Conditions
Melanoma (Skin)
Interventions
DEVICE

Patient-led surveillance

Usual care plus reminders, ASICA instructional videos, a mobile dermatoscope, an app that facilitates store-and-forward teledermatology, and fast-tracked unscheduled clinic visits.

BEHAVIORAL

Clinician-led surveillance

Usual care (scheduled clinician visits)

Trial Locations (3)

2050

Royal Prince Alfred Hospital, Sydney

2060

Melanoma Institute Australia, North Sydney

2290

Newcastle Skin Check, Newcastle

All Listed Sponsors
collaborator

Melanoma and Skin Cancer Trials Limited

OTHER

lead

University of Sydney

OTHER

NCT03581188 - Patient-led Surveillance Compared to Clinician-led Surveillance in People Treated for Localised Melanoma. | Biotech Hunter | Biotech Hunter